item management s discussion and analysis of financial condition andresults of operations results of operations fiscal compared with fiscal net sales and other revenues in fiscal were higher than in fiscal  while operating earnings and pre tax earnings showed increases of and  respectively 
operating earnings and pre tax earnings for fiscal were impacted by a pre tax charge of million for expenses recorded in the second quarter of fiscal  related to the proposed merger agreement with ivax which was terminated on march  see notes and of notes to consolidated financial statements 
had the company not recorded the million pre tax charge  operating earnings and pre tax earnings for fiscal would have increased and  respectively  compared to fiscal substantially all of the net sales and other revenues increase for fiscal reflects internal growth within both the company s existing pharmaceutical and medical surgical supply distribution businesses 
earnings per share increased compared to fiscal the average number of common and common equivalent shares outstanding increased for the earnings per share computation 
the after tax merger expenses referred to above were equivalent to 
per share 
cost of sales increased compared to fiscal  due mainly to the company s increased sales levels 
the overall gross profit as a percent of net sales and other revenues gross profit margin for fiscal decreased as a result of a decrease in gross margins due to continued price competition  partially offset by a higher mix of sales from the company s higher gross margin medical surgical supply distribution business 
the gross profit margin in the company s pharmaceutical distribution business for fiscal declined from the prior year  primarily due to competitive factors 
the gross profit margin in the company s medical surgical supply distribution business for fiscal declined over the prior year  primarily due to a higher mix of lower gross margin acute care business 
in both the pharmaceutical and medical surgical supply distribution industries  it has been customary to pass on to customers price increases from manufacturers 
investment buying enables distributors such as the company to benefit from anticipated price increases 
during periods of low inflation  which has occurred the last few years  wholesalers receive less benefit from manufacturers price increases but also incur lower lifo charges 
the rate or frequency of future price increases by manufacturers  or the lack thereof  influences the profitability of the company 
management of the company anticipates further downward pressure on gross margins in the company s pharmaceutical and medical surgical supply distribution businesses during fiscal because of continued price competition influenced by large customers 
the company expects that these pressures on operating margin may be offset to some extent by increased sales of more profitable products  such as generic drugs and medical surgical supplies  ii and continued reduction of distribution  selling  general and administrative expenses dsg a as a percentage of net sales and other revenues through more efficient operations 
dsg a  including the expenses associated with the terminated ivax merger agreement  increased  while net sales and other revenues increased 
these expenses decreased as a percent of net sales and other revenues from in fiscal to in fiscal excluding such merger expenses  dsg a in fiscal were of net sales and other revenues 
the decreased dsg a as a percent of net sales and other revenues in fiscal reflects continued operating efficiencies  including the positive effects of the consolidation of distribution locations 
net interest expense increased from million in fiscal to million in fiscal  primarily due to increased borrowings under the the company s million credit agreement the credit agreement  partially offset by decreased interest on the million senior notes notes which were repaid on january  the effective tax rate in fiscal decreased to from in fiscal reflecting the higher earnings in fiscal and  therefore  minimizing the impact of non deductible expenses 
inflation has not been a significant factor in either year 
the company uses the lifo method of accounting for inventory  which reduces the effects of inflation by reporting the cost of products sold at approximate current cost 
results of operations fiscal compared with fiscal net sales and other revenues in fiscal were higher than in fiscal  while operating earnings and pre tax earnings showed increases of and  respectively 
of the increase in net sales and other revenues  approximately was attributable to the acquisition of colonial healthcare supply co  colonial in august approximately of the net sales and other revenues increase reflected internal growth within both the company s existing pharmaceutical and medical surgical supply distribution businesses 
earnings per share increased compared to fiscal the average number of common and common equivalent shares outstanding increased for the earnings per share computation 
cost of sales increased  compared to fiscal  due mainly to the company s increased sales levels 
the overall gross profit margin for fiscal decreased as a result of a decrease in gross margins due to continued price competition and a change in customer mix in the company s pharmaceutical ii distribution business  partially offset by sales from the company s higher gross margin medical surgical supply distribution business 
the gross profit margin in the company s pharmaceutical distribution business for fiscal declined from the prior year  primarily due to competitive factors 
the gross profit margin in the company s medical surgical supply distribution business for fiscal declined over the prior year  primarily due to a higher mix of lower gross margin acute care business 
dsg a increased over fiscal  while net sales and other revenues increased over the prior year 
these expenses decreased as a percentage of net sales and other revenues from in fiscal to in fiscal the decreased dsg a as a percentage of net sales and other revenues in fiscal reflected continued operating efficiencies  including the positive effects of the continuing consolidation of distribution divisions into larger regional distribution centers  partially offset by increased dsg a in the company s medical surgical supply distribution business  principally due to the acquisition of colonial 
net interest expense decreased from million in fiscal to million in fiscal  primarily due to decreased interest on the notes which were repaid on january   and decreased borrowings under the credit agreement  partially offset by interest on the senior notes due june  notes  which were issued june  the effective tax rate in fiscal decreased to from in fiscal reflecting the higher earnings in fiscal and  therefore  minimizing the impact of non deductible expenses 
liquidity and capital resources at september   capitalization consisted of debt and equity  as compared to and  respectively  at september  the decreased debt percentage primarily reflects an increase in shareowners equity of million offset by increased borrowings under the credit agreement 
borrowings under the credit agreement were million and million at september  and  respectively 
cash and cash equivalents of million at september   increased from million at september   primarily as a result of an increase in cash flows from operating activities principally due to the company s profitable operations and increased borrowings under the credit agreement  partially offset by increases in both accounts receivable and investment in inventories net of increases in trade accounts payable 
the company filed a shelf registration statement with the securities and exchange commission which became effective on march  the registration statement allows the company to sell senior and subordinated debt or equity securities to the public from time to time up to an aggregate maximum principal amount of million 
the company intends to use the net proceeds ii from the sale of any such securities for general corporate purposes  which may include  without limitation  the repayment of indebtedness of the company or of any of its subsidiaries  possible acquisitions  capital expenditures and working capital needs 
see note of notes to consolidated financial statements 
the company s credit agreement provides for maximum borrowing up to million and has loan covenants which require the company to maintain certain financial statement ratios 
the company is in compliance with all required ratios at september  see note of notes to consolidated financial statements 
on april   the company declared a for stock split on the company s class a common stock  which was paid on june  to shareowners of record on may  dividends on class a common stock amounted to million in fiscal compared to million in fiscal  and million in fiscal  reflecting  primarily  a increase in the quarterly dividend rate during the second quarter of fiscal while the company has no policy with regard to the payment of dividends  during the three year period ended september   dividends have averaged of earnings 
capital expenditures for fiscal were million and related principally to additional investments in existing locations  the acquisition of automated warehouse equipment and additional investments in data processing equipment 
the company s working capital of million at september  increased from the million at september  and represented of total assets at september  the company s current ratio was at september   compared to at september  trade receivables outstanding  net of customer credit balances  were days for both fiscal and fiscal the inventory turnover rate on first in  first out fifo basis was times for fiscal and times for fiscal the company relies heavily on computer technology throughout its businesses to effectively carry out its day to day operations 
as the millennium approaches  the company is assessing all of its computer systems to ensure that they are year compliant 
in this process  the company expects to both replace some systems and upgrade others which are not year compliant  in order to meet its internal needs and those of its customers 
the company expects its year project to be completed on a timely basis 
however  there can be no assurance that the systems of other companies on which the company may rely also will be timely converted or that such failure to convert by another company would not have an adverse effect on the company s systems 
to date  the company has spent approximately million on the year project 
costs related to ii this project will continue through calendar these costs are difficult to estimate accurately and they will not necessarily be incremental 
the company s stated expectations regarding its year project constitute forward looking statements 
actual results could differ materially from the company s expectations due to unanticipated technological difficulties  project vendor delays and project vendor cost overruns 
reference is made to the introductory paragraph of this annual report and exhibit a hereto 
the company believes that internally generated funds  funds available under the existing credit agreement and funds potentially available under the existing shelf registration will be sufficient to meet anticipated cash and capital needs 
on november   the company signed an agreement to acquire substantially all of the net assets of besse medical services  inc  a privately held distributor of injectables  diagnostics and medical supplies 
under the agreement  the company would pay approximately million in cash  plus estimated expenses  and assume certain liabilities 
see note of notes to consolidated financial statements 
on august   the company signed a definitive merger agreement with cardinal  a distributor of pharmaceuticals and provider of value added pharmaceutical related services  headquartered in dublin  ohio 
the merger agreement  which has been unanimously approved by the boards of directors of the company and cardinal  calls for the company to become a wholly owned subsidiary of cardinal 
the combined company is expected to be known as cardinal bergen health  inc and would be headquartered in dublin  ohio 
under the terms of the proposed merger  shareowners of the company would receive of a cardinal common share in exchange for each outstanding share of the company s class a common stock 
cardinal would issue approximately million common shares in the transaction and would assume the company s long term debt which was approximately million at september  the merger of the two companies has been structured as a tax free transaction and would be accounted for as a pooling of interests for financial reporting purposes 
the merger is currently expected to be completed by the end of the second quarter of fiscal  subject to the satisfaction of certain conditions  including approvals by the company s shareowners and cardinal s shareholders  and the receipt of certain regulatory approvals 
on march   the company announced that it had terminated its previously announced merger agreement with ivax 
see notes and of notes to consolidated financial statements 
accounting pronoucements during fiscal  the company adopted statement of financial accounting standards sfas no 
 accounting for the impairment of long lived assets and for long lived assets to be disposed of 
this standard requires recognition of impairment losses on long lived assets and certain identifiable intangibles  including goodwill  used in operations  when indications of impairment are present and the undiscounted cash flows estimated to be generated by those assets are less than the assets carrying amount 
the ii adoption of this new standard did not have a material effect on the company s consolidated financial position  results of operations or cash flows 
see note of notes to consolidated financial statements 
during fiscal  the company also adopted the disclosure only provisions of sfas no 
 accounting for stock based compensation 
no compensation cost has been recognized for the company s stock option plans 
therefore  adoption of this standard had no effect on the company s consolidated financial position  results of operations or cash flows 
see note of notes to consolidated financial statements 
during fiscal  the company also adopted sfas no 
 accounting for transfers and servicing of financial assets and extinguishments of liabilities  which requires recognition of financial assets and liabilities  including receivables sold with recourse  using a financial components approach which focuses on control of the assets transferred 
this standard was effective for transfers and servicing of financial assets and extinguishments of liabilities occurring after december  the adoption of this new standard did not have a material effect on the consolidated financial statements of the company 
in february  the financial accounting standards board fasb issued sfas no 
 earnings per share eps  which will require the company to disclose basic eps and diluted eps for all periods for which an income statement is presented  and which will replace disclosure currently being made for primary eps and fully diluted eps 
the company is required to adopt this standard in its quarter ended december  see note of notes to consolidated financial statements for pro forma disclosure of basic eps and diluted eps for the three years ended september  in june  the fasb issued sfas no 
 reporting comprehensive income sfas  which establishes standards for the reporting and display of comprehensive income and its components in financial statements 
this new statement defines comprehensive income as all changes in equity during a period  with the exception of stock issuances and dividends 
in june  the fasb also issued sfas no 
 disclosures about segments of an enterprise and related information sfas which requires companies to define and report financial and descriptive information on an annual and quarterly basis about their operating segments 
this new statement also establishes standards for related disclosures about products and services  geographic areas and major customers 
both sfas and sfas will be adopted by the company s in its fiscal year 
management believes the adoption of these standards will not have a material effect on the company s consolidated financial position  results of operations or cash flows  and any effect will be limited to the form and content of its disclosures 
ii 
